Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial.
暂无分享，去创建一个
Samit R. Joshi | G. McComsey | Samir K. Gupta | C. Orrell | A. Avihingsanon | N. Ray | G. Hanna | D. Stock | M. Lataillade | O. Osiyemi | J. Lombaard | J. Echevarría | M. Santoscoy | Mario Santoscoy